Skip to content

Research at St Andrews

Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation

Research output: Contribution to journalArticle

Author(s)

Laura McAllister, Christopher Butler, Scot Mente, Steven V. O'Neil, Kari Fonseca, Justin Piro, Julie Cianfrogna, Timothy Foley, Adam Gilbert, Anthony Harris, Christopher J. Helal, Douglas S. Johnson, Justin I. Montgomery, Deane M. Nason, Stephen Noell, Jayvardhan Pandit, Bruce N. Rogers, Tarek A. Samad, Christopher L. Shaffer, Rafael G. da Silva & 3 others Daniel P. Uccello, Damien Webb, Michael A. Brodney

School/Research organisations

Abstract

Monoacylglycerol lipase (MAGL) inhibition provides a potential treatment approach to neuroinflammation through modulation of both the endocannabinoid pathway and arachidonoyl signaling in the central nervous system (CNS). Herein we report the discovery of compound 15 (PF-06795071), a potent and selective covalent MAGL inhibitor, featuring a novel trifluoromethyl glycol leaving group that confers significant physicochemical property improvements as compared with earlier inhibitor series with more lipophilic leaving groups. The design strategy focused on identifying an optimized leaving group that delivers MAGL potency, serine hydrolase selectivity, and CNS exposure while simultaneously reducing log D, improving solubility, and minimizing chemical lability. Compound 15 achieves excellent CNS exposure, extended 2-AG elevation effect in vivo, and decreased brain inflammatory markers in response to an inflammatory challenge.
Close

Details

Original languageEnglish
Pages (from-to)3008–3026
JournalJournal of Medicinal Chemistry
Volume61
Issue number7
Early online date2 Mar 2018
DOIs
Publication statusPublished - 12 Apr 2018

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Linear Eyring plots conceal a change in rate-limiting step in an enzyme reaction

    Machado, T. F. G., Gloster, T. & da Silva, R. G., 11 Dec 2018, In : Biochemistry. 57, 49, p. 6757-6761

    Research output: Contribution to journalArticle

  2. Allosteric activation shifts the rate-limiting step in a short-form ATP phosphoribosyltransferase

    Fisher, G., Thomson, C. M., Stroek, R., Czekster, C. M., Hirschi, J. S. & da Silva, R. G., 24 Jul 2018, In : Biochemistry. 57, 29, p. 4357-4367

    Research output: Contribution to journalArticle

  3. Catalytic and anticatalytic snapshots of a short-form ATP phosphoribosyltransferase

    Alphey, M. S., Fisher, G., Ge, Y., Gould, E. R., Guerreiro Machado, T. F., Liu, H., Florence, G. J., Naismith, J. H. & da Silva, R. G., 11 May 2018, In : ACS Catalysis. 8, p. 5601-5610 10 p.

    Research output: Contribution to journalArticle

  4. Kinetics and structure of a cold-adapted hetero-octameric ATP phosphoribosyltransferase

    Stroek, R., Ge, Y., Talbot, P. D., Glok, M. K., Bernas, K. E., Thomson, C. M., Gould, E. R., Alphey, M. S., Liu, H., Florence, G. J., Naismith, J. H. & da Silva, R. G., 7 Feb 2017, In : Biochemistry. 56, 5, p. 793-803 11 p.

    Research output: Contribution to journalArticle

  5. A continuous and direct assay to monitor leucine-rich repeat kinase 2 activity

    Silva, R. G., Geoghegan, K. F., Qiu, X. & Aulabaugh, A., 2014, In : Analytical Biochemistry. 450, 1, p. 63-69

    Research output: Contribution to journalArticle

Related by journal

  1. Journal of Medicinal Chemistry (Journal)

    Terry K Smith (Member of editorial board)
    2013 → …

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

Related by journal

  1. Emergence of small molecule non-RGD-mimetic inhibitors for RGD integrins

    Miller, L. M., Pritchard, J. M., Macdonald, S. J. F., Jamieson, C. & Watson, A. J. B., 30 Jan 2017, In : Journal of Medicinal Chemistry. 60, 8, p. 3241-3251

    Research output: Contribution to journalArticle

  2. Rational design of autotaxin inhibitors by structural evolution of endogenous modulators

    Keune, W-J., Potjewyd, F., Heidebrecht, T., Salgado-Polo, F., Macdonald, S. J. F., Chelvarajan, L., Abdel Latif, A., Soman, S., Morris, A. J., Watson, A. J. B., Jamieson, C. & Perrakis, A., 9 Mar 2017, In : Journal of Medicinal Chemistry. 60, 5, p. 2006-2017 12 p.

    Research output: Contribution to journalArticle

  3. Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode

    Miller, L. M., Keune, W-J., Castagna, D., Young, L. C., Duffy, E. L., Potjewyd, F., Salgado-Polo, F., Garcia, P. E., Semaan, D., Pritchard, J. M., Perrakis, A., Macdonald, S. J. F., Jamieson, C. & Watson, A. J. B., 26 Jan 2017, In : Journal of Medicinal Chemistry. 60, 2, p. 722-748 27 p.

    Research output: Contribution to journalArticle

  4. Establishment of a structure-activity relationship of the 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness

    Seixas, J. D., Luengo-Arratta, S. A., Diaz, R., Saldivia, M., Rojas-Barros, D. I., Manzano, P., Gonzalez, S., Berlanga, M., Smith, T. K., Navarro, M. & Pollastri, M. P., 12 Jun 2014, In : Journal of Medicinal Chemistry. 57, 11, p. 4834-4848 15 p.

    Research output: Contribution to journalArticle

ID: 252809602